Vecihe Bayrak

ORCID: 0000-0003-2403-8727
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Liver Disease and Transplantation
  • Long-Term Effects of COVID-19
  • Liver Disease Diagnosis and Treatment
  • Vaccine Coverage and Hesitancy
  • Ultrasound in Clinical Applications
  • Pleural and Pulmonary Diseases
  • Organ Transplantation Techniques and Outcomes
  • Inflammatory Biomarkers in Disease Prognosis
  • COVID-19 diagnosis using AI
  • Trauma Management and Diagnosis
  • Heparin-Induced Thrombocytopenia and Thrombosis

Nevşehir Hacı Bektaş Veli University
2025

Dokuz Eylül University
2021-2023

Aim: Our study aims to investigate the effect of LMR value on 30-day mortality and intensive care hospitalization days post-transplant liver patients without hepatocellular cancer(HCC) admitted unit(ICU). Methods: retrospective included post-liver transplant in ICU Dokuz Eylul University Hospital between 2010 2020. We recorded patients' age, gender, aetiology disease, donor type (living or deceased), duration cold ischemia, scores, ICU, mortality. was calculated by dividing patient's...

10.5798/dicletip.1657071 article EN Dicle Medical Journal / Dicle Tip Dergisi 2025-03-13

Background/aim: Coronavirus disease 2019 (COVID-19) is a with high rate of progression to critical illness. However, the predictors mortality in critically ill patients admitted intensive care unit (ICU) are not yet well understood. In this study, we aimed investigate risk factors associated ICU our hospital. Materials and methods: single-centered retrospective enrolled 86 adult COVID-19 Dokuz Eylül University Hospital (İzmir, Turkey) between 18 March 2020 31 October 2020. Data on...

10.3906/sag-2101-89 article EN other-oa TURKISH JOURNAL OF MEDICAL SCIENCES 2021-05-07

Pleural fluid pH measurement is recommended for tube thoracostomy decisions in complicated parapneumonic pleural effusions. However, may be affected by blood critically ill patients with common systemic acid-base disorders. We aimed to investigate the use of lactate distinguish culture-positive effusions from other effusions.This prospective observational study included 121 eligible (51 female and 70 male). All effusion who underwent thoracentesis were assessed. was measured a gas...

10.5152/thoracrespract.2023.23021 article EN cc-by-nc Thoracic research and practice 2023-08-15

To investigate the disease-specific score and improve existing scores to better determine prognosis of patients after liver transplantation (LT). For this purpose, we evaluated relationship prognostic with 30-day mortality LT. In addition, planned whether mean platelet volume/platelet count (MPR) would contribute improvement.A total 178 adult admitted intensive care unit LT in our hospital between 2011 2019 were retrospectively analyzed. Model for end-stage disease-sodium (MELDNa),...

10.5114/ceh.2022.114907 article EN Clinical and Experimental Hepatology 2022-01-01

Coronavirus disease 2019 (COVID-19) has become a part of our lives now and we have no more effective way coping than vaccine. COVID-19 is that causes severe thrombosis outside the respiratory tract. Vaccines also protect us in this respect, but some rare cases, been found to develop after vaccination (much less frequently COVID-19). What was interesting case it showed how disaster could happen under three factors predispose thrombosis. A 65-year-old female patient with disseminated...

10.7774/cevr.2023.12.2.172 article EN cc-by-nc Clinical and Experimental Vaccine Research 2023-01-01

Aim: Mortality risk factors and effective treatment approaches are still uncertain for the SARS-CoV-2.In this study, we aimed to determine of 90-day mortality critically ill patients with COVID-19 infection. Materials Methods:All hospitalized in intensive care unit university hospital diagnosis pneumonia between 15 March 30 November 2020 were reviewed retrospective study.The primary endpoint was mortality, while secondary endpoints inhospital therapy responses tocilizumab corticosteroid...

10.37678/dcybd.2022.2977 article EN Journal of Critical and Intensive Care 2022-01-01
Coming Soon ...